Does MOMETASONE Cause Therapeutic response shortened? 15 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Therapeutic response shortened have been filed in association with MOMETASONE (MOMETASONE FUROATE). This represents 0.9% of all adverse event reports for MOMETASONE.
15
Reports of Therapeutic response shortened with MOMETASONE
0.9%
of all MOMETASONE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Therapeutic response shortened From MOMETASONE?
Of the 15 reports, 6 (40.0%) required hospitalization.
Is Therapeutic response shortened Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOMETASONE. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does MOMETASONE Cause?
Asthma (522)
Dyspnoea (497)
Wheezing (459)
Gastrooesophageal reflux disease (406)
Therapeutic product effect incomplete (400)
Drug ineffective (318)
Sleep disorder due to a general medical condition (318)
Cardiac disorder (311)
Headache (308)
Loss of personal independence in daily activities (301)
What Other Drugs Cause Therapeutic response shortened?
DUPILUMAB (6,720)
ADALIMUMAB (2,597)
INFLIXIMAB-DYYB (1,837)
INFLIXIMAB (1,231)
SECUKINUMAB (1,097)
RISANKIZUMAB-RZAA (1,089)
CARBIDOPA\LEVODOPA (1,027)
ONABOTULINUMTOXINA (907)
ERENUMAB-AOOE (805)
CERTOLIZUMAB PEGOL (687)
Which MOMETASONE Alternatives Have Lower Therapeutic response shortened Risk?
MOMETASONE vs MOMETASONE FUROATE
MOMETASONE vs MOMETASONE FUROATE\OLOPATADINE
MOMETASONE vs MONOMETHYL
MOMETASONE vs MONTELUKAST
MOMETASONE vs MONTELUKAST\MONTELUKAST